Background-The best second arterial conduit for multiple arterial revascularization (MAR) is still a matter of debate.
T here is conclusive evidence that the use of a left internal thoracic artery (LITA) in coronary artery bypass grafting (CABG) surgery reduces morbidity and mortality compared with saphenous vein grafts (SVG) only. 1 Therefore, as arterial grafts are thought to provide better long term patency than SVG, it has become an implication for the routine use of more arterial grafts in the face of ever-improving stent technologies.
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Currently, multiple arterial revascularization (MAR) is performed in Ͻ13% of CABG procedures; the radial artery (RA) is most commonly used as a second conduit of choice. 2 However, outcome studies investigating the RA as a bypass conduit show conflicting results. A retrospective angiographic study by Khot et al demonstrated a significantly lower patency rate for RA compared with internal thoracic arteries (ITA) or even SVG. 3 Recently, Goldman et al showed in a prospective randomized clinical trial that RA was not superior to SVG relative to 1-year patency. 4 On the other hand, other studies have reported improved long-term survival and patency rates for patients receiving RA as a second arterial graft compared with patients receiving concomitant SVG grafts only. [5] [6] [7] In contrast to the diverging results for the RA, several observational CABG studies using the right internal thoracic artery (RITA) as a second arterial graft have shown not only superior survival but also a 60%-lower need for a further redo CABG procedure within 20 years after CABG procedure. 8 -10 Still, 1 unanswered major clinical question remains, namely, which arterial conduit used as a second graft will provide the best result relative to long-term cardiac morbidity and mortality. So far, only 2 outcome studies have addressed the short-and intermediate-term results of patients receiving either a concomitant RITA or a RA as a second conduit analyzed by a direct comparison. 11, 12 Borger et al concluded a safe use of 2 arterial grafts but could not show an advantage for either a RITA or RA graft. 11 Caputo et al did not find a survival benefit at 18 months after MAR. 12 However, in both studies, analyses were done in subgroups of patients who were not comparable in terms of relevant comorbidities and age.
As the only currently ongoing prospective study that investigates the benefit of a second ITA graft compared with SVG (the Arterial Revascularization trial, or ART), the main question of which second arterial conduit is best for CABG surgery will remains unanswered for the foreseeable future. Therefore, as the principle invesigators conclude, a prospective randomized clinical trial is very much needed. 13, 14, 15 Therefore, the aim of our propensity score-matched analysis was to evaluate the perioperative and long-term outcome of patients undergoing MAR, comparing the performance of the RA and RITA graft. In the perioperative and postoperative periods, both major cardiac and cerebrovascular events (MACCE) and MACCE-free survival were obtained to investigate the best second arterial conduit for CABG surgery.
Methods

Patients
This study analyzes all patients who underwent CABG between August 2001 and August 2010 at the Innsbruck Medical University and who received MAR with a LITA graft and either a RITA or RA bypass as a second arterial conduit. Inclusion criteria for this study were first, nonemergent isolated coronary CABG for multivessel coronary artery disease performed by a median sternotomy access. Patients suffering a prior myocardial infarction within 1 week before the CABG procedure were excluded. Additionally, patients receiving a bilateral internal thoracic artery (BITA) together with a concomitant RA (nϭ89 patients) and patients receiving a totally endoscopic CABG procedure assisted by the Da Vinci telemanipulation device for multivessel disease (either 2-vessel disease or as a hybrid procedure with concomitant percutaneous coronary intervention [PCI]) were excluded from the study (nϭ45 patients).
A total of 1001 consecutive patients undergoing MAR fulfilled the inclusion criteria of our observational study. A total of 277 patients (27.7%) received a BITA with or without concomitant SVG (BITAϮSVG group). A total of 724 patients (72.3%) received LITA together with at Ն1 RA with or without concomitant SVG grafts (LITAϩRAϮSVG group).
Surgical Technique
Sixteen different surgeons with at least 6 years of surgical experience performed both CABG procedures. There were no significant differences between the treatment groups relative to surgical experience. Surgical technique and grafting strategy did not change over the last 10 years, with the exception of the switch to skeletonization of ITA grafts in 2006. All surgeons aimed to perform an in situ RITA through the transverse sinus to graft the circumflex territories. If the RITA was too short, 2 different strategies were performed, but the choice was left to the preference of the surgeon, namely grafting the RITA to the left anterior descending artery and the RITA to circumflex territory or creation of a T-graft LITAϩRITA to bypass the left coronary system. Since the introduction of skeletonization, the success rate for using in situ RITA through the transverse sinus increased tremendously because we are now able to obtain significantly longer grafts. All RA were harvested using open surgical technique, and these patients received nitrates or diltiazem for at least 3 to 6 months after CABG surgery to avoid vasospasm. Complete revascularization was attempted in all cases.
Study End Points and Cardiac Event Assessment
The primary end point of the study was long-term overall survival and MACCE-free survival. All MACCE were defined as combined end point including (1) myocardial infarction, (2) stroke, (3) cardiacrelated death, and (4) repeated revascularization (either by PCI or CABG procedure). Perioperative myocardial infarction was defined according to the Joint Eureopean Society of Cardiology/American College of Cardiology Foundation/American Heart Association/ World Heart Federation Task Force for the Redefinition of Myocardial Infarction. 16 Perioperative neurological events were defined as postoperative new-onset neurological deficit lasting Ͼ72 hours after the appearance of symptoms.
Patient data were prospectively collected in full accordance with the standards of the Quality Control Working Group of the Austrian Society of Cardiothoracic Surgery. The data acquisition included a telephone interview by a trained study nurse a month after patient discharge to obtain 30-day mortality and morbidity. Long-term follow-up was performed by telephone interviews with patients and referring cardiologists to evaluate the freedom from angina, myocardial infarction, death from all causes, and cardiac-related deaths. Additionally, coronary angiography reports in patients who underwent repeated cardiac catheterization were obtained and evaluated. Late death was obtained from routine anniversary follow-up supplemented with the Social Security Death Index (Statistics Austria database). Permission for this study was obtained by the local institutional review board.
Propensity Score Matching and Statistical Analysis
Propensity score matching was used to reduce the impact of treatment selection in comparing RA and RITA as the second conduit for MAR. Preoperative characteristics of patients in these study groups were summarized as meanϮSD, median, or prevalence (in percentage), as appropriate. Student t test for independent sample or Mann-Whitney U test for continuous variables and 2 test for categorical variables were applied to examine differences between the BITAϮSVG and LITAϩRAϮSVG groups. Variables revealing a P value Ͻ0.2 in this analysis were entered into a logistic regression analysis with the use of RA versus RITA as the dependent variable. This was performed to generate a propensity score for each patient representing the probability to receive either a RITA or a RA as described by Blackstone 17 and Austin. 18 The resulting propensity score was used to create a matched pair patient subsample. Five-digit matching without replacement was applied to form the matched sample.
For each BITAϮSVG patient, 1 LITAϩRAϮSVG patient was randomly selected in a 1:1 manner in case of an agreement of the propensity score (2 digits behind comma). The balance of measured variables between the study groups in the matched sample was assessed using paired t test or Wilcoxon test for continuous measures and the McNemar test for categorical measures.
Kaplan-Meier analysis, together with log-rank testing, was used to evaluate the postoperative survival and MACCE-free survival in the full unmatched patient population. Finally, a Cox proportional hazards regression model stratified on matched pairs was used to estimate the treatment effect and its statistical significance relative to cumulative survival and MACCE-free survival between BITAϮSVG and LITAϩRAϮSVG groups.
Results
Patient Characteristics in the Full Unmatched Patient Population
Median follow-up of all patients was 57.7 months (range 3-112 months). Median follow-up of the BITAϮSVG group was 32.7 months (3-111 months) and 67.3 months (3-112 months) in the LITAϩRAϮSVG group (PϽ0.001). Table 1 displays preoperative characteristics of the full unmatched study population. Patients undergoing MAR receiving BITA grafts were significantly younger than patients receiving a RA as concomitant second arterial conduit but showed a significantly higher rate of chronic pulmonary obstructive disease (both PϽ0.001). Mean creatinine levels (Pϭ0.003) and dialysis before surgery (Pϭ0.009) were more frequent in this patient group (Pϭ0.009). In addition, mean ejection fraction was higher in the BITAϮSVG group (PϽ0.001). However, the prevalence of patients with impaired left ventricular function was not significantly different between patient groups (Pϭ0.22). Other cardiovascular risk factors such as diabetes mellitus, peripheral artery disease, or cerebrovascular morbidities did not differ significantly between treatment groups. Table 2 displays the intra-and postoperative outcome data of the full unmatched patient population. Mean number of Values are expressed as meansϮSD, median (range) or n (%), BITA indicates bilateral internal thoracic arteries; SVG, saphenous vein graft; LITA, left internal thoracic artery; RA, radial artery; BMI, body mass index; COPD, chronic pulmonary obstructive disease; PCI, percutaneous coronary intervention; and LVEF, left ventricular ejection fraction. Values are expressed as meanϮSD, median (range) or n (%). BITA indicates bilateral internal thoracic arteries; SVG, saphenous vein graft; ITA, internal thoracic artery; RITA, right internal thoracic artery; LAD, left anterior descending artery; RCA, right coronary artery; RA, radial artery; IABP, intra-aortic ballon pump; ICU, intensive care unit; and MACCE, major cardiac and cerebrovascular events.
Outcome in the Full Unmatched Patient Population
bypass grafts was 3.2Ϯ0.87 in the BITAϮSVG group and 3.1Ϯ0.86 grafts in the LITAϩRAϮSVG group (Pϭ0.88). The mean number of central (aortic) anastomoses was significantly higher in the LITAϩRAϮSVG group (1.1Ϯ0.75 versus 2.2Ϯ0.84 grafts, PϽ0.001). In the BITAϮSVG group, 64 patients (23.1%) did not receive any central aortic anastomosis; 162 RITA grafts (58.5%) were used as in situ grafts through the transverse sinus. Right interior transverse artery conduits used as free grafts were anastomosed as T-graft into the LITA bypass. In the BITAϮSVG group, a higher number of patients received a skeletonized ITA harvesting than in the LITAϩRAϮSVG group (67.5% versus 47.3%, PϽ0.001). Single aortic cross-clamping was performed in 5.4% and 4.4% in patients with heavily calcified aorta, respectively (Pϭ0.82). The mean perfusion time and aortic cross-clamp time was significantly longer in the BITAϮSVG group (both PϽ0.001). Intensive care unit stay was significantly shorter in the BITAϮSVG group, mean postoperative ventilation time was not different within both treatment groups (Pϭ0.23). An intra-aortic balloon pump (IABP) was implanted in 3 patients of the BITAϮSVG group (1.1%) and in 21 patients (2.9%) of the LITAϩRAϮSVG group (Pϭ0.11). Rethoracotomy because of bleeding was necessary in 4% of the BITAϮSVG and in 5.7% of the LITAϩRAϮSVG group (Pϭ0.28).
Perioperative MACCE occurred in 4 patients of the BITAϮSVG group (1.4%) and in 41 patients (5.7%) of the LITAϩRAϮSVG group (Pϭ0.004). Perioperative myocardial infarction occurred in 1 patient (0.4%) of the BITAϮSVG group and in 23 patients (3.2%) of the LITAϩRAϮSVG group (Pϭ0.009). Among these 23 patients suffering perioperative myocardial infarction, 8 patients (34.7%) had to undergo emergency CABG reoperation because of acute RA graft failure during the initial hospital stay. A new-onset neurological event was diagnosed in 1 patient (0.4%) of the BITAϮSVG group and in 18 patients (2.5%) of the LITAϩRAϮSVG group (Pϭ0.027). Perioperative death occurred in 2 patients (0.7%) of the BITAϮSVG patients and in 7 patients (1.0%) undergoing LITAϩRAϮSVG grafting (Pϭ0.70). Postoperatively, sternal dehiscence with a need for surgical intervention was not significantly different between treatment groups (3.2% versus 4.1%, Pϭ0.51). Figure 1 displays the postoperative patient survival in the full unmatched patient population. Postoperative survival at 1, 3, and 5 years was 98.9% each in the BITAϮSVG group and 96.8%, 96.3%, and 93.0% in the LITAϩRAϮSVG group (log-rank: Pϭ0.054). Figure 2 shows the MACCE-free survival at 1,3, and 5 year, which was 97.4%, 97.4%, and 95.9% in the BITAϮSVG group and 92.3%, 89.7%, and 86.4% in the LITAϩRAϮSVG group (log-rank: PϽ0.001). Table 3 displays the patient characteristics of the propensity score-matched population. Because the patients were comparable for chronic obstructive pulmonary disease (COPD) prevalence and impaired renal function, more patients in the BITAϮSVG groups had moderate or severe COPD and still higher mean preoperative creatinine levels. Table 4 shows the perioperative outcome of the propensity score-matched patient population. Perioperative MACCE occurred in 4 patients (1.4%) of the BITAϮSVG group and in 21 patients (7.6%) of the LITAϩRAϮSVG group (PϽ0.001). The perioperative myocardial infarction rate was 0.4% in the BITAϮSVG group and 3.6% in the LITAϩRAϮSVG group (both Pϭ0.01). Perioperative 
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cardiac-related death was not significantly different between treatment groups (0.7% versus 1.8%, Pϭ0.45).
A total of 118 repeated cardiac catheterization procedures among 107 patients were performed (10.7% of all patients) after a median follow-up of 32.9 months (0 -101 months) after CABG procedure. During follow up, 19 patients in the BITAϮSVG group (6.9%) and 88 patients (12.2%) in the LITAϩRAϮSVG group underwent repeated cardiac catheterization. In the BITAϮSVG group, a total of 4 (1.4%) required repeated revascularization (1 CABG reoperation, 3 by PCI intervention). In the LITAϩRAϮSVG group, 66 patients (9.1%) had pathological angiographies. In 53 patients (7.3%), disease or occlusion of Ն1 bypass conduit was diagnosed, and 40 patients received (35 by PCI, 5 by CABG reoperation) repeated revascularization during long-term follow-up. Repeated cardiac catheterization was performed in 6.9% of the BITAϮSVG group and in 37 patients (13.3%) of the LITAϩRAϮSVG group (Pϭ0.012). Repeated revascularization was necessary in 4 patients (1.4%) in the BITAϩSVG group and in 28 patients (10.1%) in the LITAϩRAϮSVG group (PϽ0.001).
A total of 313 anastomoses (132 ITA, 95 RA, and 86 SVG) were angiographically investigated. Classification of graft patency was defined according to the published definition of Khot et al. 3 Occlusion or diseased grafts were diagnosed in 13/132 (10.2%) of ITA anastomoses and in 18/86 (20.9%) anastomoses of SVG (Pϭ0.02). The worst patency rate was diagnosed for RA grafts with an occlusion/disease rate of 36/95 (37.9%) and was significantly lower than for ITA grafts (PϽ0.001) or even SVG (Pϭ0.014). Figures 3 and 4 
Discussion
The results of our study among 1001 patients provide strong evidence for the superiority of a RITA graft compared with RA as a second conduit for MAR and indicate that the RA is not an equal alternative conduit to RITA relative to both survival and cardiac-related morbidity. The propensity scorematched approach showed significant advantages of the RITA procedure not only for the perioperative, but also for the long-term outcome.
The short-term benefit of RITA grafting was demonstrated not only by a lower myocardial infarction rate, but also by a significantly reduced incidence of neurological events. The occurrence of a perioperative myocardial infarction is likely to be attributed to the known susceptibility of RA to vasospasm. 19, 20 The lower incidence of stroke almost certainly reflects less aortic manipulation when a second ITA graft is used. BITA patients received significantly fewer central aortic anastomoses (23% of BITA patients did not receive central aortic anastomoses at all), eliminating the need for partial aortic clamping and second exposure to an embolic event. Aortic manipulation is a substantial risk for stroke, especially in younger CABG patients who present with premature vulnerable soft plaques of the aorta. Plaques with soft lipid cores are difficult to localize for the surgeon and are therefore at greater risk for rupture. 21, 22 The main reason for the long-term benefit of BITA grafting lies in the anatomic structure of the ITAs that are less susceptible to atherosclerosis than RA. The lower capacity of NO release contributes to the susceptibility of RA to atherosclerosis, and is therefore responsible for the inferior longterm graft patency. 19, 20 Late graft degeneration is rare in ITA grafts, and becomes more evident with longer patient followup. 1 In our study, the RITA was preferentially used as an in situ graft in 82% of patients and was predominantly routed through the transverse sinus. An angiographic study by Ura et al 23 has found a similar high patency rate of LITA and RITA grafts at 6 years after CABG when the RITA was routed through the transverse sinus. The application of this technique may further contribute to long-term benefit in the BITA group.
Additionally, concerns about the long-term patency of RA that support our findings have previously been raised by Khot and Goldman. 3, 4 Even the preferential use of RA compared with SVG is still a matter of debate, and there is still disagreement about the relative merits of RA. [3] [4] [5] [6] [7] In one of the largest studies comparing RA and SVG, Desai et al found a significantly higher patency of RA at 1 year. However, Desai et al classified RA conduits with diffuse narrowing or string sign as patent and of little or no clinical consequence even despite inadequate blood flow. 24 This opinion, however, has been critically discussed by international experts. 25, 26 Worldwide, the RA is more frequently used than a RITA graft, mainly because of the increased risk for sternal wound complications. 2 Because deep sternal wound infection has been advocated to be an indicator for quality of care, favoring short-time results at the expense of inferior long-term outcome, most cardiac surgeons try to avoid BITA harvesting in case of availability of alternative graft material. In our study, however, sternal dehiscence was similar in both treatment groups and may be attributed to the greater likelihood that BITA patients would receive skeletonized rather than pedicled ITA grafts, thus lowering additional chest wall trauma Values are expressed as meansϮSD, median (range), or n (%). BITA indicates bilateral internal thoracic arteries; SVG, saphenous vein graft; LITA, left internal thoracic artery; RA, radial artery; BMI, body mass index; COPD, chronic obstructive pulmonary disease; PCI, percutaneous coronary intervention; and LVEF, left ventricular ejection fraction. Values are expressed as meansϮSD, median (range), or n (%). BITA indicates bilateral internal thoracic arteries; SVG, saphenous vein graft; LITA, left internal thoracic artery; RA, radial artery; ITA, internal thoracic artery; IABP, intra-aortic balloon pump; ICU, intensive care unit; and MACCE, major adverse coronary and cerebrovascular events.
and ischemia. This benefit of skeletonization of BITA has been previously reported by Saso et al. 27 Their meta-analysis of 12 studies concluded a Ͻ50% risk for sternal wound complications for skeletonized ITA grafts. Another randomized, double-blind, within-patient comparison has shown reduced postoperative pain and increased sternal perfusion after skeletonized preparation of the ITA, further supporting our results. 28 Previous studies involving BITA mainly compared RITA versus SVG rather than RITA versus RA grafts. Studies versus SVG did all show clear advantages relative to survival and occurrence of MACCE in favor of BITA. 8 -10,29 Two previous studies on MAR comparing RITA with RA, however, could not find a benefit of BITA grafting. 11, 12 In both studies, patients were not comparable in terms of baseline characteristics and revascularization strategy. In these studies, patients receiving a BITA graft were not as likely to receive the second arterial graft to the left coronary system than patients receiving a RA. In our study, however, the revascularization strategy was very similar between both treatment groups, targeting the circumflex territory with the second arterial conduit in Ͼ95% of patients. It is, however, still undecided whether the location of the second ITA influences outcome of CABG. 30, 31 Even though this is by far the largest study comparing BITA and RA, there are several limitations to mention. Although the propensity score-matching algorithm produced rather comparable groups, the study was not randomized, and we cannot rule out additional effects of missing covariates. The longer follow-up of patients in the LITAϩRAϮSVG group compared with BITAϮSVG is a further limitation for the interpretation of the findings. However, even despite shorter follow-up, there is a clear difference between early and long-term outcome supporting a benefit of BITA grafting. Survival and MACCE-free survival in the RA group of our study were very similar to the results of recently published outcome studies.
Summary
The vast majority of symptomatic patients with graft failure will preferentially undergo PCI first rather than CABG reoperation. Additionally, a substantial proportion of patients will undergo repeated cardiac reintervention unrelated to previous surgical revascularization. Because current PCI studies reach better results for left main interventions compared with noncontemporary CABG surgery, further improvement of CABG surgery by MAR with the preferential use of a BITA is warranted for all CABG patients in the future. 32 Based on the results of our study, a second ITA graft provides improved results relative to overall and MACCE-free survival compared with an additional RA; therefore, the second ITA graft ought to be used more frequently for CABG surgery in the future. We conclude that the use of RITA, but not the RA, may extend the benefits of MAR to a larger population undergoing CABG surgery, producing better long-term results even though the initial operation is longer and technically more demanding.
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